| RS867836657 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS867848081 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizure, Early-infantile DEE |
| RS867851900 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS867862540 |
CHD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS867868120 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS867868993 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS867871906 |
TASP1
|
Health Risk |
Likely pathogenic |
Suleiman-El-Hattab syndrome, Suleiman-El-Hattab syndrome |
| RS867875828 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS867879148 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS867880328 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS867880706 |
SGPL1
|
Health Risk |
Pathogenic |
— |
| RS867882536 |
HNF1B
|
Health Risk |
Likely pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS867885753 |
SPATA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS867885977 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS867904492 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Meckel-Gruber syndrome |
| RS867909116 |
NBAS
|
Health Risk |
Pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS867927445 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS867927501 |
TPP1
|
Health Risk |
Likely pathogenic |
— |
| RS867929413 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Thrombocytopenia |
| RS867929430 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS867933096 |
IL12B
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency |
| RS867941074 |
LRP2
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS867944805 |
ELP2
|
Health Risk |
Likely pathogenic |
ELP2-related disorder, ELP2-related disorder |
| RS867945364 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS867955218 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS867958037 |
MPC1
|
Health Risk |
Likely pathogenic |
Mitochondrial pyruvate carrier deficiency, Mitochondrial pyruvate carrier deficiency |
| RS867966048 |
SDHC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS867967504 |
DDX3X
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 102 |
| RS867968394 |
SCLT1
|
Health Risk |
Pathogenic |
6 conditions, 6 conditions |
| RS867969236 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS867974337 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS867975105 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Meacham syndrome |
| RS867979237 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS867982105 |
GNB1L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS867985408 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS867991237 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS867994747 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS868002181 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS868002362 |
RERE
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS868005783 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS868005849 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 1 |
| RS868010710 |
VRK1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS868011757 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS868013105 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1R, Hypertrophic cardiomyopathy 11 |
| RS868019991 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Abnormality of the musculature |
| RS868023411 |
SLC35B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 11, Treacher Collins syndrome 3 |
| RS868028669 |
GEMIN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction, Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction |
| RS868032104 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS868032740 |
SPATA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS868040089 |
PHACTR1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 70 |
| RS868044680 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS868053135 |
ARV1
|
Health Risk |
Likely pathogenic |
— |
| RS868055567 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS868057037 |
CILK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS868061310 |
NUBPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS868064056 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS868064163 |
ACTL6A
|
Health Risk |
Conflicting classifications of pathogenicity |
13 conditions, ACTL6A-related BAFopathy |
| RS868067075 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS868067982 |
IGF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS868069558 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS868073099 |
ELP1
|
Health Risk |
Pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS868074288 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS868081432 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |
| RS868081502 |
C9
|
Health Risk |
Conflicting classifications of pathogenicity |
C9-related disorder, C9-related disorder |
| RS868081622 |
MAK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS868085658 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS868085949 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS868087579 |
PUM1
|
Health Risk |
Likely pathogenic |
— |
| RS868095435 |
SETD1B
|
Health Risk |
Pathogenic |
— |
| RS868096125 |
SHH
|
Health Risk |
Pathogenic |
Partial agenesis of the corpus callosum, Partial agenesis of the corpus callosum |
| RS868097890 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS868097991 |
AARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS868098120 |
OCA2
|
Health Risk |
Pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS868107005 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHD7-related disorder |
| RS868109198 |
PPP1R12A
|
Health Risk |
Pathogenic |
Genitourinary and/or brain malformation syndrome, Genitourinary and/or brain malformation syndrome |
| RS868110178 |
CACNA1I
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with speech impairment and with or without seizures, Neurodevelopmental disorder with speech impairment and with or without seizures |
| RS868110215 |
NRAP
|
Health Risk |
Pathogenic |
— |
| RS868110599 |
ODAD1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 20, Primary ciliary dyskinesia 20 |
| RS868112062 |
CTSK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS868113829 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS868122313 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS868127074 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS868134621 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS868137297 |
TP53
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS868138294 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS868138875 |
FKRP
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Abnormality of the musculature |
| RS868138895 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS868148490 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 14, Nephronophthisis |
| RS868151020 |
DNAH5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS868153877 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS868156117 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS868157645 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS868166455 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type I |
| RS868169034 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS868174994 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS868176515 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS868183689 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS868185064 |
TRPV4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS868188730 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing impairment, Bilateral sensorineural hearing impairment |
| RS868193249 |
LDLRAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |